Home Categories API Deferoxaminemesylate
BD5107341

Deferoxaminemesylate , 98% , 138-14-7

Synonym(s):
Deferoxamine mesylate salt;DFOM;Deferoxamine methanesulfonate salt;Desferrioxamine mesylate salt;Desferrioxamine Mesylate, DFOM, Iron Chelator II

CAS NO.:138-14-7

Empirical Formula: C26H52N6O11S

Molecular Weight: 656.79

MDL number: MFCD00058605

EINECS: 205-314-3

Pack Size Price Stock Quantity
100mg RMB393.60 In Stock
250mg RMB673.60 In Stock
1g RMB1682.40 In Stock
5g RMB5047.20 In Stock
25g RMB15141.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 148-149°
storage temp.  2-8°C
solubility  H2O: 50 mg/mL
form  powder
color  white to off-white
Water Solubility  Soluble to 100 mM in water

Description and Uses

Deferoxamine is a bacterial siderophore that chelates iron. It is used to experimentally inhibit iron-dependent prolyl hydroxylases (EC50 = 17.8 μM), thus preventing the degradation of isoforms of hypoxia inducible factor during normoxia. Deferoxamine has applications in diseases that are characterized by high levels of circulating iron, such as thalassemia major.

DEFEROXAMINE MESYLATE is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319
Precautionary statements  P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Safety Statements  22-24/25
WGK Germany  2
RTECS  UG5310000
HS Code  29280000
Toxicity man,TDLo,parenteral,16gm/kg/34W-I (16000mg/kg),CARDIAC: PERICARDITISGASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINEBLOOD: OTHER CHANGES,American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987.

RELATED PRODUCTS